Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berman

Showing results (361-370 of 381) with videos related to

Pageof 39
Sort By:
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Brain : a Journal of Neurology|May 17, 2022
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiologyJohn C Morris, Michael Weiner, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trialAustin McCullough, Charles D Chen, Brian A Gordon, et al.
Pageof 39

Showing results (361-370 of 381) with videos related to

Sort By:
Pageof 39
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Brain : a Journal of Neurology|May 17, 2022
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiologyJohn C Morris, Michael Weiner, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trialAustin McCullough, Charles D Chen, Brian A Gordon, et al.
Pageof 39